10x Genomics to Report Third Quarter Financial Results on November 10, 2020
13 oct. 2020 16h15 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2020 after market close on Tuesday, November...
10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions
05 oct. 2020 16h15 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Continuing on its mission of mastering biology to advance human health, 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered...
10x Genomics Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
15 sept. 2020 16h25 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (NASDAQ: TXG) (the “Company”) today announced the closing of its public offering of 4,600,000 shares of its Class A common...
10x Genomics First to Market With Product to Simultaneously Capture Epigenome and Transcriptome
15 sept. 2020 08h00 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it has begun shipping its Chromium Single Cell Multiome ATAC + Gene Expression solution to...
10x Genomics Announces Pricing of Upsized Public Offering
10 sept. 2020 23h16 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (NASDAQ: TXG) (the “Company”) today announced the pricing of an upsized underwritten public offering by the Company of its...
10x Genomics Announces Launch of a Follow-On Public Offering
08 sept. 2020 16h20 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (NASDAQ: TXG) (the “Company”) today announced that the Company has commenced an underwritten public offering of 3,500,000...
10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference
01 sept. 2020 16h03 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. 10x...
10x Genomics Reports Second Quarter 2020 Financial Results
11 août 2020 16h05 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June 30, 2020. Recent Highlights Revenue was...
10x Genomics to Participate in the UBS Genomics 2.0 and Medtech Innovations Summit
06 août 2020 17h00 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming UBS Genomics 2.0 and Medtech Innovations Virtual...
10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19
14 juil. 2020 09h00 HE
|
10x Genomics, Inc.
PLEASANTON, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) strengthened the research toolkit of scientists around the globe today with the launch of its Chromium Single Cell...